Metraipolis › archive › dc_f702d1379d80

DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42152107
DOI
10.1186/s13046-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-02T05:27:13.842Z
SHA-256 of the archived text
08c504a1f74f176c4535d33457936aa41230114ba76edea66364d5bb8e5cfc22
Stable URL of this page
https://metraipolis.com/documento/dc_f702d1379d80

How to cite

DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107 — Europe PMC (en), https://europepmc.org/article/MED/42152107 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f702d1379d80 (Metraipolis archive dc_f702d1379d80, sha256 08c504a1f74f176c4535d33457936aa41230114ba76edea66364d5bb8e5cfc22)
BibTeX
@misc{dcf702d1379d80,
  title = {DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42152107},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f702d1379d80; sha256 08c504a1f74f176c4535d33457936aa41230114ba76edea66364d5bb8e5cfc22},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42152107. Agents can read the archived copy with the MCP tool read_document.